Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Genesis Diagnostics

1994 FOUNDED
M&A STATUS
41-50 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of diagnostic kits created to aid the diagnosis of autoimmune and infectious diseases. The company's diagnostic kits include drugs that are used in autoimmunity, immunology and microbiology laboratories for the early detection of immune reactions to food, enabling physicians to identify the early signs of any autoimmune and infectious diseases and hence start quick treatment.

Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Chemicals and Gases
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Primary Office
  • Eden Research Park
  • Henry Crabb Road
  • Littleport CB6 1SE
  • England

Genesis Diagnostics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Genesis Diagnostics‘s full profile, request access.

Request full access to PitchBook

Genesis Diagnostics Executive Team (1)

Name Title Board
Seat
Contact
Info
Mike Walker Ph.D Managing Director